Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Biphasic Insulin Aspart 50/70 vs Biphasic Human Insulin 30 in Diabetes
NCT01520818Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Mar 2000
- Primary completion
- Apr 2001
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
A Phase 3 trial of Insulin aspart + insulin aspart protamine in type 1 diabetes mellitus (T1D), type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Mar 2000; status: completed.
02
Drugs
Insulin aspart + insulin aspart protamine
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01520818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01520818.